Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Miller, Paul D; Hattersley, Gary; Riis, Bente Juel; Williams, Gregory C; Lau, Edith; Russo, Luis Augusto; Alexandersen, Peter; Zerbini, Cristiano A F; Hu, Ming-yi; Harris, Alan G; Fitzpatrick, Lorraine A; Cosman, Felicia; Christiansen, Claus.
; 316(7): 722-33, 2016 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-27533157
Abaloparatide: Review of a Next-Generation Parathyroid Hormone Agonist.
Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models.
Clinical Management of Osteoporotic Fractures.
Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.
Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Osteoanabolic and dual action drugs.
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.
Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.